Available from: Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, et al
Nearly a decade on, trends, risk factors and policy implications in global obesity
However, the recent study on semaglutide, titled Ischemic optic neuropathy with semaglutide: global observational analysis of sex- and formulation-specific risk, published in the British Journal of Ophthalmology (BJO), shows that those using Wegovy are at greater risk of developing no-artertic ischemic optic neuropathy (Naion) than Ozempic
doi: 10.3892/mmr.2025.13574 163 SimpsonAPetngaWMacaulayVMWeyer-CzernilofskyUBogenriederT
Homocysteine metabolism and the oxidative modification of proteins and lipids